Blog: Apr 2019

Please vote for us

29 April 2019

Vote and help us be in with a chance of winning £1,000!

T20K in Good Position to Become Preventive MS Treatment, Cyxone Says

10 April 2019

Source Multiple Sclerosis News Today: T20K, Cyxone‘s lead compound for treating multiple sclerosis (MS), seems able to prevent or slow disease progression, according to data from preclinical studies. Based on these findings, the company is confident that T20K might become a prophylactic (preventive) medication for MS in the near future.

Congratulations to all of our 25 Skydivers!

10 April 2019

Wow! What a day Saturday 30th March was! 25 Skydivers jumping to support the Centre.

A huge thank you to Elsa, Yvonne, Carol, Tricia, Katie, Josh, Steven, Megan, Emma, Mick, Sonia, Katie, David, Suzanne, Tim, Vicky, Kelly, Analyn, Jack, Maria, Sam, Matthew, Colette, Kerry and Peggy as well as all your supporters.

If you would like to register your interest for a future BMSTC Skydive then please contact...

New £1.8m research to explore cognitive screening and rehabilitation in multiple sclerosis

10 April 2019

Source University of Nottingham: A new £1.85 million research study led by Professor Roshan das Nair at the Institute of Mental Health aims to develop a new computerised screening tool to detect the “invisible” cognitive impairments that can appear early in the life of a person living with multiple sclerosis (MS).

Anyone taking Plegridy?

10 April 2019

Source MS Trust: NICE will be assessing Plegridy to decide whether it should continue to be prescribed by the NHS in England. We’ll be telling NICE why we think it should be an option. If you are taking Plegridy we’d really like to know what you think of it, your experiences good and bad.

Access improvements at 73 railway stations

10 April 2019

Source BBC: Lifts and adjustable ticket counters will be among the new measures brought in over the next five years.

The changes, part of an "inclusive transport strategy", will help disabled passengers as well as those travelling with children or luggage. Liverpool Central and Luton in England, Barry Town in Wales, and Dumfries in Scotland are among the stations chosen.

The Department for Transport says the sites were selected based on criteria which included their usage,...

Gabapentin and pregabalin - new rules for prescriptions

10 April 2019

Source MS Trust: From 1 April 2019, gabapentin and pregabalin have been reclassified as controlled drugs, leading to changes in how they are prescribed.

Gabapentin and pregabalin are drugs used to treat a range of symptoms caused by MS, such as nerve pain, spasticity and spasms.

Following concerns about misuse of these drugs, on 1 April the law changed so that it is now illegal to possess gabapentin or pregabalin without a prescription and to supply or to sell them to others...

Mitochondria and progressive MS

10 April 2019

Source MS Society: Small but mighty, mitochondria provide the energy that busy nerve cells need to survive.

We spoke with mitochondria expert Dr Don Mahad, from the University of Edinburgh, about what makes them so special - and what goes wrong in MS.

Mitochondria and progressive MS

‘I’m interested in energy production and demand in the brain and spinal cord, and especially how this changes in progressive MS.’ It’s the mitochondria that generate the bulk of this...

Scrap the PIP 20-metre rule

10 April 2019

Source MS Society: Scrap the PIP 20-metre rule.

Motability offers manual wheelchair lease to customers

10 April 2019

Source Independent Living: An interesting new supplementary service has just been launched by Motability.

Category

Archive